Li Chao, Li Xuan, Qu Wen, Ma He-ping, Gao Feng, Cui Zhong-qi
Department of Cardiac Surgery, Third Hospital, Peking University, Beijing 100083, China.
Zhonghua Wai Ke Za Zhi. 2003 Mar;41(3):197-200.
To evaluate the basic procedure of endovascular stent-graft repair in the treatment of aortic arch aneurysm.
From March 2000-February 2002, a total of 46 patients with aortic arch aneurysms were treated with the custom-made endovascular stent-graft. Of them, twenty-three patients (50%) had aneurysms at the middle of the arch, 22 patients (48%) had aneurysms at the arch-descending aorta, and 1 patient (2%) had aneurysm at the descending thoracic aorta. The diameter of all stents was 0.15 - 0.25 times larger than that of the aorta proximal to the entry tear of dissection or the opening of aneurysm. The diameter of the proximal end of the stents was ranged from 34 - 38 mm. The length of stents ranged from 90 - 120 mm. The stent was made of shape memory nitinol.
The stent was delivered successfully in 45 patients (98%). None of the patients had any access-related complications. Either the primary entry tear of aortic dissection or the inlet of aneurysm was occluded in 43 patients (96%), with an early endoleak in 2 patients (4%). All truth lumen of the dissection recovered to normal. Of the patients in acute period, 1 was referred to surgical repair and 2 died. Follow-up for 1 month to 23 months, showed late endoleak in 3 patients (7%). Forty-three patients restored normal life.
Endovascular stent-graft could be applied in the repair of aortic arch aneurysm. Further studies are needed to to assess the long-term efficacy of this method.
评估血管内支架移植物修复术治疗主动脉弓动脉瘤的基本操作流程。
2000年3月至2002年2月,共有46例主动脉弓动脉瘤患者接受了定制的血管内支架移植物治疗。其中,23例患者(50%)动脉瘤位于弓中部,22例患者(48%)动脉瘤位于弓降部,1例患者(2%)动脉瘤位于胸降主动脉。所有支架的直径比夹层入口撕裂或动脉瘤开口近端的主动脉直径大0.15 - 0.25倍。支架近端直径范围为34 - 38mm。支架长度范围为90 - 120mm。支架由形状记忆镍钛合金制成。
45例患者(98%)成功植入支架。所有患者均无与入路相关的并发症。43例患者(96%)的主动脉夹层原发入口撕裂或动脉瘤入口被封堵,2例患者(4%)出现早期内漏。所有夹层的真腔均恢复正常。急性期患者中,1例转至外科修复,2例死亡。随访1个月至23个月,3例患者(7%)出现晚期内漏。43例患者恢复正常生活。
血管内支架移植物可应用于主动脉弓动脉瘤的修复。需要进一步研究以评估该方法的长期疗效。